Apricus Bio awards Neopharm exclusive rights to advertise and sell Vitaros in Israel and Palestinian Territories Apricus Biosciences, Inc. In exchange, Apricus Bio is entitled to receive up to total of $4.35 million in up-front, regulatory and sales milestone obligations for the merchandise. Further, over the life span of the agreement, Apricus Bio shall receive tiered, double-digit royalties predicated on Neopharm’s sales of the merchandise.’.To see the online edition of the International Journal of Clinical Therapeutics and Pharmacology, visit:.
Anxiety disorders connected with higher threat of cardiovascular occasions, deaths in cardiovascular disease patients Among patients with heart disease, anxiety disorders appear to be associated with an increased threat of stroke, heart attack, heart death and failure, in the July issue of Archives of General Psychiatry according to a report, among the JAMA/Archives journals. As many as 24 % to 31 % of individuals with heart disease likewise have symptoms of panic, according to background information in this article.